AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
Cantor Fitzgerald has initiated coverage on AbbVie Inc ABBV, a global pharma company. The analyst notes that the company has positioned itself to absorb Humira biosimilar erosion and achieve modest operational revenue growth. Related: Ex-Humira Growth …